PubMed Central
metadata only
CC BY 4.0
Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design
There is currently no approved vaccine for Shigella spp., a leading cause of diarrhea with increasing rates of antimicrobial resistance. Shigella vaccine development is complicated in part by an incomplete understanding of the structural and molecular determinants of immunity. To address this, we is
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A low resource requirement molecular diagnostic and surveillance tool for Shigella in the era of vaccination#486262
- A low resource requirement molecular diagnostic and surveillance tool for Shigella in the era of vaccination#386996
- Estimating the impact of Shigella vaccines on growth outcomes and implications for clinical trial design#151576
- Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a#876033
- Phase 2 Shigella Vaccine and Challenge#321563
Record · ID 1252741
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive